Skip to main content
Log in

Multiobjective Optimization Approach in Evaluation of Chromatographic Behaviour of Zolpidem Tartrate and Its Degradation Products

  • Original
  • Published:
Chromatographia Aims and scope Submit manuscript

Abstract

Multiresponse optimization methodology in combination with experimental design was employed as a powerful technique for simultaneous optimization of input variables significant for evaluation of chromatographic behaviour of zolpidem tartrate, zolpacid, oxozolpidem, zolpyridine and zolpaldehyde towards various responses. In the first stage of the investigation fractional factorial design was used to decrease the number of variables that should be studied in detail. Among examined variables, pH of the mobile phase, percentage of organic modifier and buffer concentration showed to be statistically important and were consequently optimized with central composite design and Derringer’s desirability function. Four responses were considered, the retention factors of zolpacid and zolpaldehyde (the first and last peak) and the resolutions between critical peaks. Optimal conditions included Luna C18(2) analytical column (250 mm x 4.6 mm, 5 μm particle size), mobile phase consisted of methanol–10 mM ammonium acetate (68.4:31.6, v/v, pH 5.4) and column temperature of 35 °C. The flow rate of the mobile phase was 1 mL min−1 and the detection was performed at 254 nm. At the end, the method was successfully validated in accordance with ICH guideline and subsequently applied to the analysis of commercially available zolpidem tartrate tablets.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Sweetman SC (ed) (2009) Martindale: the complete drug reference 36. Pharmaceutical Press, London

    Google Scholar 

  2. Dollery C (ed) (1999) Therapeutic drugs, 2nd edn. Edinburgh, Churchill Livingstone

    Google Scholar 

  3. ICH Q3B (R2) (2003), revision included (2006) Fed Regist 68:64628–64629

  4. Ring PR, Bostick JM (2000) J Pharm Biomed Anal 22:495–504

    Article  CAS  Google Scholar 

  5. Nirogi RVS, Kandikere VN, Shrivasthava W, Mudigonda K (2006) Biomed Chromatogr 20:1103–1108

    Article  CAS  Google Scholar 

  6. Ptacek P, Macek J, Klima J (1997) J Chromatogr B 694:409–413

    Article  CAS  Google Scholar 

  7. Ascalone V, Flaminio L, Guinebault P, Thenot JP, Morselli PL (1992) J Chromatogr 581:237–250

    Article  CAS  Google Scholar 

  8. Tracqui A, Kintz P, Mangin P (1993) J Chromatogr 616:95–103

    Article  CAS  Google Scholar 

  9. Wang Q, Sun L, Lau CE (1999) J Chromatogr B 734:299–305

    Article  CAS  Google Scholar 

  10. Villain M, Cheze M, Tracqui A, Ludes B, Kintz P (2004) Forensic Sci Int 143:157–161

    Article  CAS  Google Scholar 

  11. Giroud C, Augsburger M, Menetrey A, Mangin P (2003) J Chromatogr B 789:131–138

    Article  CAS  Google Scholar 

  12. Kintz P, Villain M, Ludes B (2004) J Chromatogr B 811:59–63

    CAS  Google Scholar 

  13. Bhatt J, Jangid A, Shetty R, Shah B, Kambli S, Subbaiah G, Singh S (2006) Biomed Chromatogr 20:736–742

    Article  CAS  Google Scholar 

  14. Stanke F, Jourdil N, Bessard J, Bessard G (1996) J Chromatogr B 675:43–51

    Article  CAS  Google Scholar 

  15. Gaillard Y, Gay-Montchamp JP, Ollagnier M (1993) J Chromatogr 622:197–208

    Article  CAS  Google Scholar 

  16. Keller T, Schneider A, Tutsch-Bauer E (1999) Forensic Sci Int 106(2):103–108

    Article  CAS  Google Scholar 

  17. Winek CL, Wahba WW, Janssen JK, Rozin L, Rafizadeh V (1996) Forensic Sci Int 78:165–168

    Article  CAS  Google Scholar 

  18. Hempel G, Blaschke G (1996) J Chromatogr B 675:131–137

    Article  CAS  Google Scholar 

  19. El Zeany BA, Moustafa AA, Farid NF (2003) J Pharm Biomed Anal 33:393–401

    Article  CAS  Google Scholar 

  20. Laviana L, Mangas C, Fernandez-Mari F, Bayod M, Blanco D (2004) J Pharm Biomed Anal 36:925–928

    Article  CAS  Google Scholar 

  21. Council of Europe (2008) European Pharmacopoeia, 6th edn. Council of Europe, Strasbourg

    Google Scholar 

  22. Preu M, Guyot D, Petz M (1998) J Chromatogr A 818:95–108

    Article  CAS  Google Scholar 

  23. Martendal E, Budziak D, Carasek E (2007) J Chromatogr A 1148:131–136

    Article  CAS  Google Scholar 

  24. Ferreira SLC, Bruns RE, Paranhos da Silva EG, Lopes dos Santos WN, Quintella CM, David JM, Bittencourt de Andrade J, Breitkreitz MC, Jardim ICSF, Neto BB (2007) J Chromatogr A 1158:2–14

    Article  CAS  Google Scholar 

  25. Nowak M, Seubert A (1999) J Chromatogr A 855:91–109

    Article  CAS  Google Scholar 

  26. Bezerra MA, Santelli RE, Oliveira EP, Villar LS, Escaleira LA (2008) Talanta 76:965–977

    Article  CAS  Google Scholar 

  27. Zecevic M, Jocic B, Zivanovic Lj, Protic A (2008) Chromatographia 68:911–918

    Article  CAS  Google Scholar 

  28. Candioti LV, Robles JC, Mantovani VE, Goicoechea HC (2006) Talanta 69:140–147

    Article  CAS  Google Scholar 

  29. Safa F, Hadjmohammadi MR (2005) J Chromatogr A 1078:42–50

    Article  CAS  Google Scholar 

  30. Ortiz MC, Herrero A, Sanllorente S, Reguera C (2005) Talanta 65:246–254

    CAS  Google Scholar 

  31. Jeong IJ, Kim KJ (2009) Eur J Oper Res 195:412–426

    Article  Google Scholar 

  32. Sivakumar T, Manavalan R, Muralidharan C, Valliappan K (2007) J Pharm Biomed Anal 43:1842–1848

    Article  CAS  Google Scholar 

  33. Zivanovic Lj, Protic A, Zecevic M, Jocic B, Kostic M (2009) J Pharm Biomed Anal 50:640–648

    Article  CAS  Google Scholar 

  34. Candioti LV, Olivieri AC, Goicoechea HC (2007) Anal Chim Acta 595:310–318

    Article  Google Scholar 

  35. ICH Q2 (R1) (1997) addendum incorporated (2005) Fed Regist 62:27463–27467

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ljiljana Zivanovic.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Malesevic, M., Zivanovic, L., Protic, A. et al. Multiobjective Optimization Approach in Evaluation of Chromatographic Behaviour of Zolpidem Tartrate and Its Degradation Products. Chromatographia 74, 197–208 (2011). https://doi.org/10.1007/s10337-011-2064-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10337-011-2064-9

Keywords

Navigation